Sanofi : FDA Approves Dupixent For Young Children With Moderate-to-severe Atopic Dermatitis

Sanofi (SNYNF,SNY) and Regeneron Pharmaceuticals Inc. (REGN) said that the U.S. Food and Drug Administration has approved Dupixent or dupilumab for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.

The companies noted that regulatory filings for the age group are underway by the European Medicines Agency and regulatory authorities in additional countries.

According to the company, Children treated with Dupixent and topical corticosteroids achieved clearer skin, experienced significantly improved overall disease severity and significantly reduced itch compared to topical corticosteroids alone at week 16 in a Phase 3 trial.

Long-term safety data from a 52-week open-label extension trial in the age group reinforce the well-established safety profile of Dupixent observed across all other approved age groups.

Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy through adulthood, the companies said in a statement.

Atopic dermatitis is a chronic type 2 inflammatory skin disease. Eighty-five to ninety percent of patients first develop symptoms before 5 years of age, which can often continue through adulthood. Symptoms include intense, persistent itch and skin lesions that cover much of the body, resulting in skin dryness, cracking, pain, redness or darkening, and crusting and oozing.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Specialty athletic retailer Foot Locker, Inc. reported Friday a second-quarter net profit that plunged from last year, hurt by a sales decline amid markdowns. Quarterly sales met Street estimates. The company also trimmed it adjusted earnings and sales growth guidance for the full-year 2022. Google's hundreds of employees have signed a petition sent to executives demanding extension of abortion care benefits to contract workers. The workers also called to halt donations given to anti-abortion politicians and to expand travel benefits. The petition, circulated by the Alphabet Workers Union, has been signed by over 650 employees at Google's parent company Alphabet Inc. Apple Inc. has released an emergency security update noting that some of its iPhones, iPads and Macs had certain vulnerabilities. The tech major said the flaws potentially allow full admin access to devices. The models affected by the issue include iPhone 6S and later models, several models of the newer iPads, and Mac computers running macOS Monterey and above. The flaws also affect the iPod Touch
Follow RTT